Mangoceuticals (MGRX) Short-term Investments (2023 - 2026)

Mangoceuticals' Short-term Investments history runs 4 years deep, the most recent figure standing at $16957.0 for Q1 2026.

• In Q1 2026, Short-term Investments changed 0.09% year-over-year to $16957.0; the TTM figure through Mar 2026 stood at $16957.0 (changed 0.09% YoY), while the FY2025 annual figure was $33899.0, up 100.09% from the prior year.
• Short-term Investments came in at $16957.0 for Q1 2026 at Mangoceuticals, down from $33899.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $33899.0 in Q4 2025 to a low of $16942.0 in Q4 2023.
• A 4-year average of $19063.5 and a median of $16942.0 in 2023 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments changed 0.0% in 2024 and soared 100.09% in 2025, its largest moves.
• Mangoceuticals' Short-term Investments stood at $16942.0 in 2023, then changed by 0.0% to $16942.0 in 2024, then jumped by 100.09% to $33899.0 in 2025, then slumped by 49.98% to $16957.0 in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $16957.0, $33899.0, and $16942.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison